Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Cancers|January 21, 2023
A Phase II, Open-Label Clinical Trial of Intranasal Ketamine for Depression in Patients with Cancer Receiving Palliative Care (INKeD-PC Study)Joshua D Rosenblat, Froukje E deVries, Zoe Doyle, et al.
Journal of Psychopharmacology (Oxford, England)|July 1, 2025
Examining mystical experiences as a predictor of psilocybin-assisted psychotherapy for treatment-resistant depressionRyan M Brudner, Erica Kaczmarek, Marc G Blainey, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|December 6, 2024
Examining the impact of comorbid posttraumatic stress disorder on ketamine's real-world effectiveness in treatment-resistant depressionDanica E Johnson, Nelson B Rodrigues, Sydney Weisz, et al.
Journal of Pain and Symptom Management|April 29, 2026
Intranasal Ketamine for Existential Distress in Advanced CancerStefan Aguiar, Mary Makarious, Orly Lipsitz, et al.
Journal of Psychopharmacology (Oxford, England)|May 17, 2023
Real-world effectiveness of repeated intravenous ketamine infusions for treatment-resistant depression in transitional age youthNoah Chisamore, Kevork Danayan, Nelson B Rodrigues, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 24, 2025
Cognitive outcomes following psilocybin-assisted therapy in treatment-resistant depression: A post-hoc analysis of a randomized, waitlist-controlled trialDanica E Johnson, Shakila Meshkat, Erica S Kaczmarek, et al.
Psychiatry Research|March 8, 2023
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorderKevork Danayan, Noah Chisamore, Nelson B Rodrigues, et al.
Med (New York, N.Y.)|February 15, 2024
Psilocybin-assisted psychotherapy for treatment resistant depression: A randomized clinical trial evaluating repeated doses of psilocybinJoshua D Rosenblat, Shakila Meshkat, Zoe Doyle, et al.
Pageof 2